Sexual behaviour and infection rates for HIV, blood-borne and sexually transmitted infections among patients attending drug treatment centres in Rio de Janeiro, Brazil

被引：27

作者：

Bastos, FI ^{[1
]}

Lowndes, CM ^{[1
]}

Derrico, M ^{[1
]}

Castello-Branco, LR ^{[1
]}

Linhares-de-Carvalho, MI ^{[1
]}

Oelemann, W ^{[1
]}

Bernier, F ^{[1
]}

Morgado, MG ^{[1
]}

Yoshida, CF ^{[1
]}

Rozental, T ^{[1
]}

Alary, M ^{[1
]}

机构：

[1] Fundacao Oswaldo Cruz, CICT, DIS, Dept Informacoes Saude, BR-21045900 Rio De Janeiro, Brazil

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 2000年 / 11卷 / 06期

关键词：

drug users; HIV infection; sexually transmitted infections; viral hepatitis; drug treatment centres;

D O I：

10.1258/0956462001916100

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A survey was carried out in 2 drug use treatment centres (TCs) in Rio de Janeiro, Brazil, to assess risk behaviours, HN infection and other sexually transmitted infections/blood-borne infections (STIs/BBIs). Two hundred and twenty-five drug users (195 males and 30 females) were interviewed and clinically examined, and their blood and urine were tested for STIs/BBIs. Prevalences (%) for these infections were as follows - HIV: 0.9, hepatitis B virus (HBV): 14.7, hepatitis C virus (HCV): 5.8, syphilis: 5.3, gonorrhoea/chlamydia (CT/NG): 4.7. In bivariate analyses CT/NG infection was associated with younger age (P=0.003); current genitourinary symptoms (odds ratio [OR]=6.2) and a mainly illegal source of income (OR=9.1). Hepatitis C infection was associated with a history of ever having injected any drug (OR=19.6), and with each one of the injected drugs. After multiple logistic regression, lower educational level (adjusted odds ratio [AOR]=3.70) and 'ever having injected drugs' (AOR=3.69) remained as independent risk factors for hepatitis B infection. In conclusion, TCs must implement programmes directed towards the prevention of STIs/BBIs.

引用

页码：383 / 392

页数：10

共 36 条

[1] Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil [J].

Andrade, TM ;

Dourado, I ;

Galvao-Castro, B .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) :186-187

[2] NEW EVIDENCE ON INTRAVENOUS COCAINE USE AND THE RISK OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

ANTHONY, JC ;

VLAHOV, D ;

NELSON, KE ;

COHN, S ;

ASTEMBORSKI, J ;

SOLOMON, L .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) :1175-1189

[3] Drug use and the spread of HIV/AIDS in South America and the Caribbean [J].

Bastos, FI ;

Strathdee, SA ;

Derrico, M ;

Pina, MD .

DRUGS-EDUCATION PREVENTION AND POLICY, 1999, 6 (01) :29-49

[4]

BASTOS FI, 1995, OS MUITOS BRASIS SAU, P245

[5]

BASTOS WS, 1996, 2 SEM INT SOBR TOX R, V28

[6]

Carvalho Heraclito Barbosa De, 1996, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V12, P84

[7]

Cotrim BC., 1998, JOVENS ACONTECENDO N, V2, P645

[8] Perception of vulnerability to HIV infection ill a cohort of homosexual/bisexual men in Rio de Janeiro, Brazil [J].

de Souza, CTV ;

Bastos, FI ;

Lowndes, CM ;

Szwarcwald, CL ;

dos Santos, EM ;

De Castilho, EA ;

Sutmoller, F .

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1999, 11 (05) :567-579

[9]

DEAN AD, 1990, EPI INFO VERSION 6 W

[10]

DesJarlais DC, 1997, SEX TRANSM DIS, V24, P320

← 1 2 3 4 →